By: Positively Aware (NOV+DEC 2016)

Previously known as Fulyzaq (generic name crofelemer), the only FDA-approved drug for treating HIV-related diarrhea has been acquired by Napo Pharmaceuticals and is now marketed under the name Mytesi. The company has launched patient co-pay and patient assistance programs to allow for broader access to Mytesi. For details, go to